CNNC INT'L (02302) releases its interim results, with a net profit attributable to shareholders of HK$10.35 million, turning a loss into a profit year-on-year.
China Nuclear International (02302) has released its interim performance for the six months ending June 30, 2025, with revenue of 5.92...
CNNC INT'L (02302) announced its interim results for the six months ended June 30, 2025, with revenue of HK$592 million, a year-on-year increase of 9151.72%; profit attributable to shareholders was HK$10.359 million, compared to a loss of HK$7.731 million in the same period last year, turning a loss into a profit; basic earnings per share was HK$0.212.
The announcement stated that the significant increase in revenue during the review period was mainly due to a substantial increase in the trading volume of the Group's uranium trading business, with the vast majority of revenue of approximately HK$582 million coming from the sale of natural uranium to independent third parties.
Related Articles

US Stock Market Move | Ethereum concept stocks rose sharply, with SharpLink Gaming (SBET.US) rising more than 3.4%.

US Stock Market Move | Q2 net sales hit a record high, Semtech Corporation (SMTC.US) surged more than 16%

Macau L.J. (01680) issues profit warning, expecting a decrease of approximately 12% in the total reported earnings for the mid-term compared to the same period last year.
US Stock Market Move | Ethereum concept stocks rose sharply, with SharpLink Gaming (SBET.US) rising more than 3.4%.

US Stock Market Move | Q2 net sales hit a record high, Semtech Corporation (SMTC.US) surged more than 16%

Macau L.J. (01680) issues profit warning, expecting a decrease of approximately 12% in the total reported earnings for the mid-term compared to the same period last year.

RECOMMEND

Analysts Respond to Trump’s Dismissal of Fed Governor Cook as a Further Assault on Central Bank Independence
26/08/2025

U.S. Proposes Including Copper, Silicon, Silver on 2025 Critical Minerals List Amid Supply Chain Concerns
26/08/2025

Trump Vows to Slash U.S. Drug Prices by Up to 1500%, Triggering Sell-Off in Pharma Stocks
26/08/2025